Kiromic Biopharma, Inc. Financing Cash Flow
Kiromic Biopharma, Inc. reported Financing Cash Flow of $18.41 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-02-14
- Kiromic Biopharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $2.42M, a 44.38% decline year-over-year.
- Kiromic Biopharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $1.03M, a 85.33% decline year-over-year.
- Kiromic Biopharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $8.78M, a 23.48% increase year-over-year.
- Kiromic Biopharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was $6.19M, a 11.83% increase year-over-year.
- Kiromic Biopharma, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $18.41M, a 23.24% decline from fiscal 2023.
- Kiromic Biopharma, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $23.99M, a 514.73% increase from fiscal 2022.
- Kiromic Biopharma, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $3.90M, a 89.55% decline from fiscal 2021.
- Kiromic Biopharma, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $37.34M, a 136.22% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $3.44M derived: sum of 2 quarters · filed 2025-02-14 | $12.22M derived: sum of 3 quarters · filed 2025-02-14 | $18.41M 10-K · filed 2025-02-14 | ||||
| 2024-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $9.81M derived: sum of 2 quarters · filed 2024-11-08 | $16.00M 10-Q · filed 2024-11-08 | $20.34M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-06-30 | $8.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $14.97M 10-Q · filed 2024-08-09 | $19.32M derived: sum of 3 quarters · filed 2025-02-14 | $26.32M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-03-31 | $6.19M 10-Q · filed 2024-05-10 | $10.53M derived: sum of 2 quarters · filed 2025-02-14 | $17.54M derived: sum of 3 quarters · filed 2025-02-14 | $24.65M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $11.34M derived: sum of 2 quarters · filed 2025-02-14 | $18.45M derived: sum of 3 quarters · filed 2025-02-14 | $23.99M 10-K · filed 2025-02-14 | $23.99M 10-K · filed 2024-03-19 | |||
| 2023-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $14.11M derived: sum of 2 quarters · filed 2024-11-08 | $19.65M 10-Q · filed 2024-11-08 | $19.65M 10-Q · filed 2023-11-14 | $24.01M derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | $7.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $12.65M 10-Q · filed 2024-08-09 | $12.65M 10-Q · filed 2023-08-14 | $17.01M derived: sum of 3 quarters · filed 2024-08-09 | $16.89M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $5.54M 10-Q · filed 2024-05-10 | $5.54M 10-Q · filed 2023-05-15 | $9.89M derived: sum of 2 quarters · filed 2024-05-10 | $9.78M derived: sum of 3 quarters · filed 2024-05-10 | $9.61M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $4.24M derived: sum of 2 quarters · filed 2024-03-19 | $4.07M derived: sum of 3 quarters · filed 2024-03-19 | $3.90M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | -$114.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$285.70K derived: sum of 2 quarters · filed 2023-11-14 | -$454.50K 10-Q · filed 2023-11-14 | $100.00 derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$170.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$339.60K 10-Q · filed 2023-08-14 | $115.00K derived: sum of 3 quarters · filed 2023-08-14 | $37.14M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$168.80K 10-Q · filed 2023-05-15 | $285.80K derived: sum of 2 quarters · filed 2023-05-15 | $37.31M derived: sum of 3 quarters · filed 2023-05-15 | $37.30M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $454.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $37.48M derived: sum of 2 quarters · filed 2023-04-17 | $37.47M derived: sum of 3 quarters · filed 2023-04-17 | $37.34M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | $37.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $37.02M derived: sum of 2 quarters · filed 2022-11-14 | $36.88M 10-Q · filed 2022-11-14 | $49.58M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$10.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$145.40K 10-Q · filed 2022-08-12 | $12.55M derived: sum of 3 quarters · filed 2022-08-12 | $12.54M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$134.60K 10-Q · filed 2022-05-13 | $12.56M derived: sum of 2 quarters · filed 2022-05-13 | $12.55M derived: sum of 3 quarters · filed 2022-05-13 | $12.67M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $12.69M derived: sum of 2 quarters · filed 2022-04-08 | $12.81M derived: sum of 3 quarters · filed 2022-04-08 | $15.81M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-11 | $110.50K derived: sum of 2 quarters · filed 2022-03-11 | $3.11M 10-Q · filed 2022-03-11 | $6.04M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $120.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $3.12M 10-Q · filed 2021-08-13 | $6.05M derived: sum of 3 quarters · filed 2021-08-13 | |||||
| 2020-03-31 | $3.00M 10-Q · filed 2021-05-14 | $5.93M derived: sum of 2 quarters · filed 2021-05-14 | ||||||
| 2019-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $4.76M 10-K · filed 2021-03-31 | ||||||
| 2019-09-30 | $1.83M 10-Q · filed 2020-11-30 |